Hortapharm B.V.

[3] HortaPharm B.V. has used selective breeding and production for research of cannabis strains, with a focus on the isolation of tetrahydrocannabinol or cannabidiol.

[5] Lab Supervisor, David Pate, gave a lecture at the National Academy of Sciences in Washington, D. C. on February 24, 1998, as part of the Institute of Medicine study to evaluate the therapeutic value of marijuana and its chemical components.

[6] In March of 2000, HortaPharm B.V. filed a patent for a vaporizer with enhanced isolation chambers for ascending-steam extraction, with the invention attributed to David Pate.

[7] GW Pharmecuticals have filed multiple patents based on their work with HortaPham B.V.

You can help Wikipedia by expanding it.This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.